Home

Search Abstracts

Browse Sessions

Program Committee

Conference Webcasts

Contact Us

---

Session 129   Poster Abstracts Treatment in Pregnant Women and Children: Toxicity Wednesday, 1:30 - 3:30 pm Poster Hall

938	Toxicity with Continuous Nevirapine in Pregnancy: Results from PACTG 1022 J Hitti*1, L Frenkel1, S Huang2, L Wei2, L Stevens3, H Watts4, J McNamara4, and PACTG 1022 Study Team 1Univ. of Washington, Seattle, USA; 2Harvard Sch. of Publ. Hlth., Boston, MA, USA; 3Frontier Sci. and Technology Res. Fndn., Buffalo, NY, USA; and 4NIH, DHHS, Bethesda, MD, USA
939	Adverse Events to Nevirapine Therapy during Pregnancy S J Bershoff-Matcha*1, L M Mundy2, and J V Henry1 1Kaiser Permanente of the Mid-Atlantic States, Washington, DC, USA and 2Washington Univ. Sch. of Med., St. Louis, MO, USA
940	Toxicity Related to Antiretroviral Therapy in a Cohort of HIV Pregnant Women of Buenos Aires A Duran*, F Masciottra, J Toibaro, L Lourtau, S Ivalo, and M Losso Hosp. Ramos Mejia, Buenos Aires, Argentina
941	Lactic Acid Levels in Infants Exposed to ART during Fetal Life C Giaquinto*1, O Rampon1, S Torresan1, E Ruga1, A De Rossi2, A Burlina1, M Sturkenboom3, and R D' Elia1 1Univ. of Padova, Italy; 2Inst of Oncology, Univ. of Padova, Italy; and 3Erasmus Univ. Med Sch., Rotterdam, The Netherlands
942	Lack of Hyperlactatemia and Impaired Mitochondrial DNA Content in CD4+ Cells of HIV-uninfected Infants Exposed to Perinatal Antiretroviral Therapy A Vigano*1, R Bianchi1, L Schneider1, L Cafarelli1, R Tornaghi1, M Pinti2, N Prada2, and A Cossarizza2 1Univ. of Milan, Italy and 2Univ. of Modena and Reggio Emilia, Italy
943	Analysis of Bone Mineral Content in Antiretroviral-naive and Highly Active Antiretroviral-treated HIV-infected Children A Vigano*1, I Zamproni2, V Giacomet1, R Bianchi1, C Figini1, and S Mora2 1L. Sacco Hosp., Milan, Italy and 2Lab. of Pediatric Endocrinology, Sci. Inst. H. San Raffaele, Milan, Italy
944	Hepatic Toxicity of Antiretrovirals in HIV-infected Pregnant Women: A Review of the FDA's Adverse Event Reporting System M Baylor*, M Truffa, and N Gibbs FDA, Rockville, MD, USA